HuGE Literature Finder
Records 1-18
|
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
|
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
Frontiers in oncology 2020 10 571189. Xu Yang, Li Renpeng, Li Xiaoxia, Dong Naijun, Wu Di, Hou Lin, Yin Kan, Zhao Chunh |
|
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
|
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse gliomarwith molecular genetic features of primary glioblastoma.
Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
|
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.
Journal of neuro-oncology 2018 Apr . Wijnenga Maarten M J, French Pim J, Dubbink Hendrikus J, Dinjens Winand N M, Atmodimedjo Peggy N, Kros Johan M, Fleischeuer Ruth, Dirven Clemens M F, Vincent Arnaud J P E, van den Bent Martin |
|
Racial Disparities in the Molecular Landscape of Cancer.
Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
|
Sexual dimorphism in glioma glycolysis underlies sex differences in survival.
JCI insight 2017 Aug 2 (15): . Ippolito Joseph E, Yim Aldrin Kay-Yuen, Luo Jingqin, Chinnaiyan Prakash, Rubin Joshua |
|
PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis.
OncoTargets and therapy 2016 9 3485-92. Han Feng, Hu Rong, Yang Hua, Liu Jian, Sui Jianmei, Xiang Xin, Wang Fan, Chu Liangzhao, Song Shib |
|
Diagnostic yield of targeted next generation sequencing in various cancer types: An information-theoretic approach.
Cancer genetics 2015 Sep 208 (9): 441-7. Hagemann Ian S, O'Neill Patrick K, Erill Ivan, Pfeifer John |
|
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
|
Retraction Note to: relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Aug . Xiao Wei-Zhong, Han Dong-Hua, Wang Fei, Wang Yong-Qian, Zhu You-Hou, Wu Yi-Fang, Liu Ning-Tao, Sun Ji-Yo |
|
Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jul 35 (7): 6687-93. Xiao Wei-Zhong, Han Dong-Hua, Wang Fei, Wang Yong-Qian, Zhu You-Hou, Wu Yi-Fang, Liu Ning-Tao, Sun Ji-Yo |
|
Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2014 Jun 68 (5): 521-6. Stankovic Tijana, Milinkovic Vedrana, Bankovic Jasna, Dinic Jelena, Tanic Nasta, Dramicanin Tatjana, Tanic Niko |
|
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
|
IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas.
International journal of clinical oncology 2012 Dec 17 (6): 551-61. Shibahara Ichiyo, Sonoda Yukihiko, Kanamori Masayuki, Saito Ryuta, Yamashita Yoji, Kumabe Toshihiro, Watanabe Mika, Suzuki Hiroyoshi, Kato Shunsuke, Ishioka Chikashi, Tominaga Tei |
|
Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate.
Anticancer research 2010 Mar 30 (3): 981-5. Yang Yiling, Shao Naiyuan, Luo Guanghua, Li Lu, Zheng Lu, Nilsson-Ehle Peter, Xu Ni |
|
Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas.
Cellular and molecular neurobiology 2009 Jul 29 (5): 733-8. Cecener Gulsah, Tunca Berrin, Egeli Unal, Bekar Ahmet, Guler Gulnur, Vatan Ozgur, Tolunay Sahsi |
|
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Aug 16 (8): 1655-61. Rajaraman Preetha, Wang Sophia S, Rothman Nathaniel, Brown Merideth M, Black Peter M, Fine Howard A, Loeffler Jay S, Selker Robert G, Shapiro William R, Chanock Stephen J, Inskip Peter |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jun 09, 2021
- Content source: